Justin F Gainor

Dr. Justin F Gainor, a medical oncologist from Massachusetts General Hospital, delves into groundbreaking treatments for ALK-positive metastatic non-small cell lung cancer. He discusses the effectiveness of ALK inhibitors, exploring strategies for optimizing treatments and identifying exceptional responders. The conversation highlights the complexities of managing young patients, including family planning and the implications of various therapies. Gainor also addresses the importance of monitoring CNS effects, weight gain challenges, and innovative approaches to treatment resistance.